The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
Open accessAbstract
Alshetaiwi et al. identify CD84 to be a robust MSDC-specific cell surface marker in breast cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215
Yang, B.-J., Han, X.-X., Yin, L.-L., Xing, M.-Q., Xu, Z.-H., & Xue, H.-W. (2016) · Nature Communications · doi:10.1038/ncomms11388 · Cited by 1,202
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Condamine, T., Dominguez, G. A., Youn, J.-I., Kossenkov, A. V., Mony, S., Alicea-Torres, K., Tcyganov, E., Hashimoto, A., Nefedova, Y., Lin, C., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf8943 · Cited by 789
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4666 · Cited by 725
Kumar, V., Donthireddy, L., Marvel, D., Condamine, T., Wang, F., Lavilla-Alonso, S., Hashimoto, A., Vonteddu, P., Behera, R., Goins, M. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.005 · Cited by 653
Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062602 · Cited by 652
Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Casbon, A.-J., Reynaud, D., Park, C., Khuc, E., Gan, D. D., Schepers, K., Passegué, E., & Werb, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424927112 · Cited by 470
Highfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., et al. (2010) · Blood · doi:10.1182/blood-2010-06-287839 · Cited by 465
Fusarium: Molecular Diversity and Intrinsic Drug Resistance
Al-Hatmi, A. M. S., Meis, J. F., & de Hoog, G. S. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005464 · Cited by 432
Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Odze, R., Glickman, J. N., & Garrett, W. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.024 · Cited by 402 · cited 1×
“Besides their immunosuppressive function, MDSCs may also actively shape the tumor microenvironment through complex cross-talk with breast cancer cells and surrounding stroma, resulting in increased angiogenesis, tumor invasion, and metastasis (8, 10, 11).”
BackgroundGiladi, A., Paul, F., Herzog, Y., Lubling, Y., Weiner, A., Yofe, I., Jaitin, D., Cabezas-Wallscheid, N., Dress, R., Ginhoux, F., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0121-4 · Cited by 366
Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., Voronov, E., & Apte, R. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8200 · Cited by 290
SOCS3 Is a Critical Physiological Negative Regulator of G-CSF Signaling and Emergency Granulopoiesis
Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L. A., Sutherland, K. D., Hartley, L., Williams, E., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00022-6 · Cited by 285
Cross, S. S., Hamdy, F. C., Deloulme, J. C., & Rehman, I. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02097.x · Cited by 259
Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae
Deniset, J. F., Surewaard, B. G., Lee, W.-Y., & Kubes, P. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161621 · Cited by 231
SLAM receptors and SAP influence lymphocyte interactions, development and function
Schwartzberg, P. L., Mueller, K. L., Qi, H., & Cannons, J. L. (2009) · Nature Reviews Immunology · doi:10.1038/nri2456 · Cited by 221
Gao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L., & Bing, C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2013 · Cited by 213
Ma, G., Pan, P.-Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., & Chen, S.-H. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.004 · Cited by 174
Si, Y., Merz, S. F., Jansen, P., Wang, B.-X., Bruderek, K., Altenhoff, P., Mattheis, S., Lang, S., Gunzer, M., Klode, J., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw9159 · Cited by 145
Martı́n, M., Ros, X. R., de la Fuente, M. Á., Tovar, V., Zapater, N., Esplugues, E., Pizcueta, P. M., Bosch, J., & Engel, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3668 · Cited by 137
Oppermann, S., Ylanko, J., Shi, Y., Hariharan, S., Oakes, C. C., Brauer, P. M., Zúñiga‐Pflücker, J. C., Leber, B. F., Spaner, D., & Andrews, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-687814 · Cited by 123
Roles and regulation of phospholipid scramblases
Kodigepalli, K. M., Bowers, K., Sharp, A., & Nanjundan, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.11.036 · Cited by 121
Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
Leroy, C., Ramos, P. M., Cornille, K., Bonenfant, D., Fritsch, C. M., Voshol, H., & Bentires‐Alj, M. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0697-1 · Cited by 112
CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion
Zhu, H., Gu, Y., Xue, Y., Yuan, M., Cao, X., & Liu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.23020 · Cited by 104
Jitschin, R., Saul, D., Braun, M., Tohumeken, Ş., Völkl, S., Kischel, R., Lutteropp, M., Santos, C. D., Mackensen, A., & Mougiakakos, D. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0432-9 · Cited by 93
Ortiz, M. L., Kumar, V., Martner, A., Mony, S., Donthireddy, L., Condamine, T., Seykora, J. T., Knight, S. C., Malietzis, G. A., Lee, G. H., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140835 · Cited by 82
IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
Yu, F., Xie, D., Ng, S. S., Lum, C. T., Cai, M.-Y., Cheung, W. K. W., Kung, H., Lin, G., Wang, X., & Lin, M. C.-M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.034 · Cited by 81
Ogony, J. W., Choi, H. J., Lui, A. J., Cristofanilli, M., & Lewis-Wambi, J. S. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0683-7 · Cited by 77
Karlstetter, M., Walczak, Y., Weigelt, K., Ebert, S., den Brulle, J. V., Schwer, H., Fuchshofer, R., & Langmann, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903300 · Cited by 70
CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia
Lewinsky, H., Barak, A. F., Huber, V., Kramer, M. P., Radomir, L., Sever, L., Orr, I., Mirkin, V., Dezorella, N., Shapiro, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96610 · Cited by 70
Hirai, H., Fujishita, T., Kurimoto, K., Miyachi, H., Kitano, S., Inamoto, S., Itatani, Y., Saitou, M., Maekawa, T., & Taketo, M. M. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9684-z · Cited by 69
Neutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation
Weber, D. A., Sumagin, R., McCall, I. C., Leoni, G., Neumann, P. A., Andargachew, R., Brazil, J. C., Contreras, O. M., Denning, T. L., Nusrat, A., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.12 · Cited by 63
Hawkins, R. W., Patenaude, A., Dumas, A., Jain, R. W., Tesfagiorgis, Y., Kerfoot, S. M., Matsui, T., Gunzer, M., Poubelle, P. E., Larochelle, C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.96882 · Cited by 59
Cuenca, M., Sintes, J., Lányi, Á., & Engel, P. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.10.017 · Cited by 53
Sari, I. N., Yang, Y., Phi, L. T., Kim, H., Baek, M. J., Jeong, D., & Kwon, H. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13325 · Cited by 49
Giuliani, A., eds, & RINALDI, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-594-1 · Cited by 33
CD84 mediates CLL-microenvironment interactions
Marom, A., Barak, A. F., Kramer, M. P., Lewinsky, H., Binsky, I., Cohen, S., Tsitsou-Kampeli, A., Kalchenko, V., Kuznetsov, Y., Mirkin, V., et al. (2016) · Oncogene · doi:10.1038/onc.2016.238 · Cited by 33
Cited by
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Metadata
- Authors
- Alshetaiwi, H., Pervolarakis, N., McIntyre, L. L., Ma, D., Nguyen, Q., Rath, J. A., Nee, K., Hernandez, G., Evans, K., Torosian, L., Silva, A., Walsh, C., & Kessenbrock, K.
- Venue
- Science Immunology
- Published
- 2020-02-14
- Volume
- 5
- Issue
- 44
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W3007604420
- Cited by
- 537
- References
- 55
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.